| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |